200 institutions reported holding $1.76B of MAZE THERAPEUTICS INC (MAZE) in SEC 13F filings for 2026-06-30. Largest institutional holders: Frazier Life Sciences Management, L.P. ($150.2M), TRV GP IV, LLC ($133.5M), ARCH Venture Management, LLC ($123.0M), Deep Track Capital, LP ($111.4M), BlackRock, Inc. ($104.5M). Source: SEC Form 13F.
Source: SEC Form 13F filings · as of 2026-06-30